Audit data

We share data from the Case Mix Programme and the National Cardiac Arrest Audit to support critical and emergency care research in a variety of ways.

To inform sample size calculations

Examples include:

  • Selective Decontamination of the Digestive Tract in the ICU (SuDDICU) randomised controlled trial – Dr Tony Gordon, Imperial College, London
  • Protective ventilation with veno-venous lung assist in respiratory failure (the REST Trial) – Professor Danny McAuley, The Queen’s University of Belfast
  • Continuous veno-venous haemofiltration for septic shock – Dr Duncan Young, University of Oxford

To minimise duplicate data collection in primary research studies

Examples include:

  • GlyCon, a multi-centre, retrospective study of Glycaemic Control of Stress Hyperglycaemia Implemented in NHS Intensive Care Units – María del Rocío Fernández Méndez, University of Nottingham
  • Intensive Care Outcome Network (ICON), a multi-centre, longitudinal study of survivors of critical illness – Dr Duncan Young, University of Oxford
  • Intensive Care After-care Network-UK (iCAN-UK), a study of the long-term economic impact of critical illness and its association with health related quality of life in patients discharged from intensive care units in the United Kingdom – Dr Steve Brett, Imperial Healthcare NHS Trust, London
  • Sepsis Pathophysiological and Organisational Timing ((SPOT)light and (SPOT)id) – Dr Steve Harris, London School of Hygiene & Tropical Medicine
  • Beta Agonist Lung Injury Trial 2 (BALTI-2), a multi-centre UK study into the effects of an intravenous infusion of salbutamol on the 28 day outcome of ventilated patients with ARDS – Professor Fang Gao Smith, University of Warwick
  • Tracheostomy Management in critical care (TracMan), a multicentre, randomised controlled trial to determine whether “early” or “late” tracheostomy placement in critically ill adult patients requiring ventilatory support influences hospital mortality – Dr Duncan Young, University of Oxford
  • Pre-hospital randomised assessment of a mechanical compression device in cardiac arrest (PARAMEDIC) – Professor Gavin Perkins, University of Warwick
  • Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP 2), testing the hypothesis that treatment with enteral simvastatin 80 mg once daily for a maximum of 28 days will be of therapeutic value in patients with acute lung injury (ALI) – Professor Danny McAuley, Royal Group of Hospitals Trust, Belfast
  • Pandemic influenza triage in the emergency department (PAINTED) – Professor Steve Goodacre, University of Sheffield

For secondary and mixed methods research

Examples include:

  • Avoidable mortality from in-hospital cardiac arrest – Dr Helen Hogan, London School of Hygiene & Tropical Medicine
  • High-intensity Specialist Led Acute Care (HiSLAC) – Professor Julian Bion, University of Birmingham
  • Protected Pharmacy – Dr Rob Schulman, University College Hospital, London
  • Impact of the English pro-choice reforms on adult critical care – Professor Carol Propper, Imperial College London and University of Bristol
  • UK Consultant Cover Census (UK-3Cs) – Dr Elizabeth Wilcox, Toronto Western Hospital, Canada
  • Selective Decontamination of the Digestive Tract in the ICU (SuDDICU) survey of current practice – Professor Brian Cuthbertson, Sunnybrook Hospital, Toronto, Canada
  • The Cardiac Output Monitoring EvaluaTion - UK (COMET-UK) Study – Dr Saxon Ridley, Glan Clwyd Hospital, Rhyl
  • International comparisons of critical care provision and outcomes – Dr Hannah Wunsch, Columbia University, New York, US
  • Modernisation of adult critical care services – Dr Andrew Hutchings, London School of Hygiene & Tropical Medicine

For secondary analyses

Examples include:

  • Nursing workforce and outcome, Professor Elizabeth West, University of Greenwich, London
  • Volume-outcome relationship among mechanically ventilated admissions – Dr Jason Shahin, McGill University, Montreal, Canada
  • Children admitted to adult critical care units – Dr Padmanabhan Ramnarayan, Children’s Acute Transport Service, London
  • Neurological admissions to critical care – Dr Maxwell Damian, Addenbrooke’s Hospital, Cambridge
  • Effect of non-clinical critical care unit to critical care unit transfers – Dr Helen Barratt, University College, London
  • Volume-outcome relationship among admissions with severe sepsis – Dr Jason Shahin, McGill University, Montreal, Canada
  • Cirrhosis patients admitted to critical care – Dr Alastair O’Brien, University College Hospital, London
  • Temperature and outcome in critically ill patients with and without infection – Dr Paul Young, Wellington Regional Hospital, New Zealand
  • Admissions with haematological malignancies – Dr Peter Hampshire, Royal Liverpool University Hospital
  • Admissions following oesophagectomy – Dr Daniel Park, University of Birmingham
  • Dermatological admissions to critical care – Dr Susannah George, St Helier Hospital, Carshalton
  • Admissions following cardiopulmonary resuscitation – Dr Jerry Nolan, Royal United Hospital, Bath
  • Admissions with acute kidney injury – Dr Nitin Kolhe, Derby City Hospital
  • Admissions requiring chronic renal dialysis – Dr Colin Hutchison, Queen Elizabeth Medical Centre, Birmingham
  • Admissions with severe acute pancreatitis – Dr Giovanna D’Amico, University College Hospital, London
  • Admissions following high risk surgery – Professor Rupert Pearse, Queen Mary University of London
  • Admissions with community acquired pneumonia – Dr Mark Woodhead, Manchester Royal Infirmary
  • Admissions following head injury – Mr Jonny Hyam, Charing Cross Hospital, London
  • Admissions with chronic obstructive pulmonary disease – Dr Martin Wildman, London School of Hygiene & Tropical Medicine
  • Obstetric admissions to critical care – Dr James Penny, East Surrey Hospital, Redhill
  • Admissions with asthma – Dr Deerhaj Gupta, Birmingham Heartlands Hospital

Copyright © 2021 ICNARC